A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells

PLoS One. 2018 May 16;13(5):e0197162. doi: 10.1371/journal.pone.0197162. eCollection 2018.

Abstract

Background: Pipeline comparisons for gene expression data are highly valuable for applied real data analyses, as they enable the selection of suitable analysis strategies for the dataset at hand. Such pipelines for RNA-Seq data should include mapping of reads, counting and differential gene expression analysis or preprocessing, normalization and differential gene expression in case of microarray analysis, in order to give a global insight into pipeline performances.

Methods: Four commonly used RNA-Seq pipelines (STAR/HTSeq-Count/edgeR, STAR/RSEM/edgeR, Sailfish/edgeR, TopHat2/Cufflinks/CuffDiff)) were investigated on multiple levels (alignment and counting) and cross-compared with the microarray counterpart on the level of gene expression and gene ontology enrichment. For these comparisons we generated two matched microarray and RNA-Seq datasets: Burkitt Lymphoma cell line data and rectal cancer patient data.

Results: The overall mapping rate of STAR was 98.98% for the cell line dataset and 98.49% for the patient dataset. Tophat's overall mapping rate was 97.02% and 96.73%, respectively, while Sailfish had only an overall mapping rate of 84.81% and 54.44%. The correlation of gene expression in microarray and RNA-Seq data was moderately worse for the patient dataset (ρ = 0.67-0.69) than for the cell line dataset (ρ = 0.87-0.88). An exception were the correlation results of Cufflinks, which were substantially lower (ρ = 0.21-0.29 and 0.34-0.53). For both datasets we identified very low numbers of differentially expressed genes using the microarray platform. For RNA-Seq we checked the agreement of differentially expressed genes identified in the different pipelines and of GO-term enrichment results.

Conclusion: In conclusion the combination of STAR aligner with HTSeq-Count followed by STAR aligner with RSEM and Sailfish generated differentially expressed genes best suited for the dataset at hand and in agreement with most of the other transcriptomics pipelines.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Burkitt Lymphoma* / genetics
  • Burkitt Lymphoma* / metabolism
  • Burkitt Lymphoma* / pathology
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic*
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Oligonucleotide Array Sequence Analysis / methods*
  • RNA, Neoplasm* / biosynthesis
  • RNA, Neoplasm* / genetics
  • Rectal Neoplasms* / genetics
  • Rectal Neoplasms* / metabolism
  • Rectal Neoplasms* / pathology

Substances

  • RNA, Neoplasm

Grants and funding

Funding for this study provide by: Bundesministerium für Bildung und Forschung, MetastaSys (0316173A), Prof. Tim Beißbarth; Bundesministerium für Bildung und Forschung (DE), MyPathSem (031L0024), Prof. Tim Beißbarth; Bundesministerium für Bildung und Forschung, HER2LOW (031A429), Prof. Tim Beißbarth; Bundesministerium für Bildung und Forschung, MMML-Demonstrators (031A428), Dieter Kube; Deutsche Forschungsgemeinschaft, Open Access Publication Funds of the Göttingen University, Not applicable.